A citation-based method for searching scientific literature

Maximilian J Mair, Marjolein Geurts, Martin J van den Bent, Anna S Berghoff. Cancer Treat Rev 2021
Times Cited: 26







List of co-cited articles
82 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
38

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
Michael Weller, Martin van den Bent, Matthias Preusser, Emilie Le Rhun, Jörg C Tonn, Giuseppe Minniti, Martin Bendszus, Carmen Balana, Olivier Chinot, Linda Dirven,[...]. Nat Rev Clin Oncol 2021
321
30

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J Brat, Roel G W Verhaak, Kenneth D Aldape, W K Alfred Yung, Sofie R Salama, Lee A D Cooper, Esther Rheinbay, C Ryan Miller, Mark Vitucci, Olena Morozova,[...]. N Engl J Med 2015
26

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
26

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Pieter Wesseling, Daniel J Brat, Ian A Cree, Dominique Figarella-Branger, Cynthia Hawkins, H K Ng, Stefan M Pfister, Guido Reifenberger,[...]. Neuro Oncol 2021
23

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Michele Ceccarelli, Floris P Barthel, Tathiane M Malta, Thais S Sabedot, Sofie R Salama, Bradley A Murray, Olena Morozova, Yulia Newton, Amie Radenbaugh, Stefano M Pagnotta,[...]. Cell 2016
19

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
19

WHO 2016 Classification of gliomas.
P Wesseling, D Capper. Neuropathol Appl Neurobiol 2018
380
19

Primary brain tumours in adults.
Sarah Lapointe, Arie Perry, Nicholas A Butowski. Lancet 2018
533
19

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, Arnab Chakravarti, Mark R Gilbert, Geoffrey R Barger, Stephen Coons, Peter Ricci, Dennis Bullard, Paul D Brown,[...]. N Engl J Med 2016
536
15

MGMT gene silencing and benefit from temozolomide in glioblastoma.
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M Kros, Johannes A Hainfellner, Warren Mason, Luigi Mariani,[...]. N Engl J Med 2005
11

Malignant gliomas in adults.
Patrick Y Wen, Santosh Kesari. N Engl J Med 2008
11

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets.
Sue Han, Yang Liu, Sabrina J Cai, Mingyu Qian, Jianyi Ding, Mioara Larion, Mark R Gilbert, Chunzhang Yang. Br J Cancer 2020
146
11

Glioblastoma and other malignant gliomas: a clinical review.
Antonio Omuro, Lisa M DeAngelis. JAMA 2013
11

Clinical practice guidelines for the management of adult diffuse gliomas.
Tao Jiang, Do-Hyun Nam, Zvi Ram, Wai-Sang Poon, Jiguang Wang, Damdindorj Boldbaatar, Ying Mao, Wenbin Ma, Qing Mao, Yongping You,[...]. Cancer Lett 2021
95
11

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
11

Advancements in Neuroimaging to Unravel Biological and Molecular Features of Brain Tumors.
Francesco Sanvito, Antonella Castellano, Andrea Falini. Cancers (Basel) 2021
9
33

IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
David E Reuss, Yasin Mamatjan, Daniel Schrimpf, David Capper, Volker Hovestadt, Annekathrin Kratz, Felix Sahm, Christian Koelsche, Andrey Korshunov, Adriana Olar,[...]. Acta Neuropathol 2015
189
11

Molecular markers in glioma.
Kirsten Ludwig, Harley I Kornblum. J Neurooncol 2017
191
11

Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.
C Mircea S Tesileanu, Martin J van den Bent, Marc Sanson, Wolfgang Wick, Alba A Brandes, Paul M Clement, Sara C Erridge, Michael A Vogelbaum, Anna K Nowak, Jean F Baurain,[...]. Neuro Oncol 2021
15
20

Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients.
Zheng Zhao, Ke-Nan Zhang, Qiangwei Wang, Guanzhang Li, Fan Zeng, Ying Zhang, Fan Wu, Ruichao Chai, Zheng Wang, Chuanbao Zhang,[...]. Genomics Proteomics Bioinformatics 2021
175
11

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
Kosuke Aoki, Hideo Nakamura, Hiromichi Suzuki, Keitaro Matsuo, Keisuke Kataoka, Teppei Shimamura, Kazuya Motomura, Fumiharu Ohka, Satoshi Shiina, Takashi Yamamoto,[...]. Neuro Oncol 2018
148
11

Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes.
Christian Vannahme, Neil Smyth, Nicolai Miosge, Silke Gösling, Christian Frie, Mats Paulsson, Patrik Maurer, Ursula Hartmann. J Biol Chem 2002
79
7

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.
Antonio Colaprico, Tiago C Silva, Catharina Olsen, Luciano Garofano, Claudia Cava, Davide Garolini, Thais S Sabedot, Tathiane M Malta, Stefano M Pagnotta, Isabella Castiglioni,[...]. Nucleic Acids Res 2016
7

SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors.
Florence Brellier, Sabrina Ruggiero, Daniela Zwolanek, Enrico Martina, Daniel Hess, Marianne Brown-Luedi, Ursula Hartmann, Manuel Koch, Adrian Merlo, Maddalena Lino,[...]. Matrix Biol 2011
29
7

WGCNA: an R package for weighted correlation network analysis.
Peter Langfelder, Steve Horvath. BMC Bioinformatics 2008
7

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Christian Hartmann, Jochen Meyer, Jörg Balss, David Capper, Wolf Mueller, Arne Christians, Jörg Felsberg, Marietta Wolter, Christian Mawrin, Wolfgang Wick,[...]. Acta Neuropathol 2009
814
7

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
Marc Sanson, Yannick Marie, Sophie Paris, Ahmed Idbaih, Julien Laffaire, François Ducray, Soufiane El Hallani, Blandine Boisselier, Karima Mokhtari, Khe Hoang-Xuan,[...]. J Clin Oncol 2009
727
7

Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.
L Poetsch, C Bronnimann, H Loiseau, J S Frénel, A Siegfried, R Seizeur, G Gauchotte, D Cappellen, C Carpentier, D Figarella-Branger,[...]. J Neurooncol 2021
11
18

IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients.
Ni Chen, Tianpin Yu, Jing Gong, Ling Nie, Xueqin Chen, Mengni Zhang, Miao Xu, Junya Tan, Zhengzheng Su, Jinjing Zhong,[...]. Pathology 2016
24
8

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis.
Philippe Metellus, Bema Coulibaly, Carole Colin, Andre Maues de Paula, Alexandre Vasiljevic, David Taieb, Anne Barlier, Blandine Boisselier, Karima Mokhtari, Xiao Wei Wang,[...]. Acta Neuropathol 2010
218
7

Analysis of the IDH1 codon 132 mutation in brain tumors.
Jörg Balss, Jochen Meyer, Wolf Mueller, Andrey Korshunov, Christian Hartmann, Andreas von Deimling. Acta Neuropathol 2008
766
7

A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53.
Sandra Camelo-Piragua, Michael Jansen, Aniruddha Ganguly, James ChulMin Kim, Arjola K Cosper, Dora Dias-Santagata, Catherine L Nutt, A John Iafrate, David N Louis. J Neuropathol Exp Neurol 2011
57
7

Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas.
Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Santino Minichillo, Antonella Mura, Sofia Asioli, Daniela Bartolini, Marina Gardiman, Marco Gessi, Claudio Ghimenton,[...]. Eur J Cancer 2020
12
16

Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
Lonneke A M Gravendeel, Nanne K Kloosterhof, Linda B C Bralten, Ronald van Marion, Hendrikus Jan Dubbink, Winand Dinjens, Fonnet E Bleeker, Casper C Hoogenraad, Erna Michiels, Johan M Kros,[...]. Hum Mutat 2010
77
7

The somatic genomic landscape of glioblastoma.
Cameron W Brennan, Roel G W Verhaak, Aaron McKenna, Benito Campos, Houtan Noushmehr, Sofie R Salama, Siyuan Zheng, Debyani Chakravarty, J Zachary Sanborn, Samuel H Berman,[...]. Cell 2013
7

The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas.
Hao-Yuan Wang, Kai Tang, Ting-Yu Liang, Wei-Zhong Zhang, Ji-Ye Li, Wen Wang, Hui-Min Hu, Ming-Yang Li, Hui-Qing Wang, Xiao-Zheng He,[...]. J Exp Clin Cancer Res 2016
48
7

Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
Melike Pekmezci, Terri Rice, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Helen Hansen, Hugues Sicotte, Thomas M Kollmeyer, Lucie S McCoy, Gobinda Sarkar,[...]. Acta Neuropathol 2017
183
7

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, Willy Hugo, Alexander H Lee, Tom B Davidson, Anthony C Wang, Benjamin M Ellingson, Julie A Rytlewski, Catherine M Sanders,[...]. Nat Med 2019
565
7

Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
Pei Yang, Yongzhi Wang, Xiaoxia Peng, Gan You, Wei Zhang, Wei Yan, Zhaoshi Bao, Yinyan Wang, Xiaoguang Qiu, Tao Jiang. J Neurooncol 2013
104
7

Ten-year survival in glioblastoma. A systematic review.
Tomasz Tykocki, Mohamed Eltayeb. J Clin Neurosci 2018
130
7

Survival in glioblastoma: a review on the impact of treatment modalities.
P D Delgado-López, E M Corrales-García. Clin Transl Oncol 2016
328
7

Radiomics and radiogenomics in gliomas: a contemporary update.
Gagandeep Singh, Sunil Manjila, Nicole Sakla, Alan True, Amr H Wardeh, Niha Beig, Anatoliy Vaysberg, John Matthews, Prateek Prasanna, Vadim Spektor. Br J Cancer 2021
36
7

Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution.
Zhaoshi Bao, Yongzhi Wang, Qiangwei Wang, Shengyu Fang, Xia Shan, Jiguang Wang, Tao Jiang. Front Med 2021
15
13

Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features.
Hong Peng, Jiaohua Huo, Bo Li, Yuanyuan Cui, Hao Zhang, Liang Zhang, Lin Ma. J Magn Reson Imaging 2021
17
11


Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
7


Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, Clemens Mayer, Mirjana Efremova, Dietmar Rieder, Hubert Hackl, Zlatko Trajanoski. Cell Rep 2017
7

EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.
Eskil Eskilsson, Gro V Røsland, Gergely Solecki, Qianghu Wang, Patrick N Harter, Grazia Graziani, Roel G W Verhaak, Frank Winkler, Rolf Bjerkvig, Hrvoje Miletic. Neuro Oncol 2018
132
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.